[Federal Register Volume 68, Number 86 (Monday, May 5, 2003)]
[Notices]
[Pages 23719-23720]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-10977]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-03-64]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 498-1210.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Send comments to Anne O'Connor, CDC 
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.
    Proposed Project: Evaluation Of Educational Materials Promoting 
Informed Decision-Making About Prostate Cancer Screening--New--National 
Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), 
Centers for Disease Control and Prevention (CDC).
    Prostate cancer is the second most commonly diagnosed cancer among 
men in the United States. An estimated 220,900 new cases of prostate 
cancer will be diagnosed, and 28,900 men will die from the disease in 
2003. The effectiveness of prostate cancer screening has not been 
established. A number of clinical guidelines recommend that the 
potential risks and benefits of prostate cancer screening be explained 
to patients so that they may make an informed decision about screening. 
The purpose of this project is to evaluate the effectiveness of an 
informed-decision making booklet about prostate cancer screening 
developed by CDC.
    The proposed study will consist of 3 tasks. In Task 1, the 
reliability and validity of a measurement instrument assessing prostate 
cancer knowledge and related variables will be tested. Two hundred men 
of all races aged 50 to 70 years and 200 African-American men aged 40 
to 70 years will read the CDC booklet and complete the measurement 
instrument. In Task 2, 250 primary care physicians will complete a 
survey measuring their prostate cancer screening practices. The survey 
will be administered once and then again several months later. In Task 
3, 600 men aged 50-70 years will take part in a randomized controlled 
trial. Men in the intervention group will be asked to read the CDC 
booklet and complete the measurement instrument tested in Task 1, and 
men in the control group will complete the measurement instrument 
without reading the CDC booklet. There is no cost to respondent except 
for their time.

[[Page 23720]]



----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
                   Respondents                       Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Men, all races aged 50-70 years (validation                  200               1           90/60             300
 study).........................................
African-American men aged 40-70 years                        200               1           90/60             300
 (validation study).............................
Primary care physicians.........................             250               2           15/60             125
Men, all races aged 50-70 years (intervention                300               1           90/60             450
 group).........................................
Men, all races aged 50-70 years (control group).             300               1               1             300
                                                 -----------------
    Total.......................................  ..............  ..............  ..............           1,475
----------------------------------------------------------------------------------------------------------------


    Dated: April 29, 2003.
Thomas Bartenfeld,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention.
[FR Doc. 03-10977 Filed 5-2-03; 8:45 am]
BILLING CODE 4163-18-P